humalog
eli lilly and company (nz) limited - insulin lispro 100 u/ml; - solution for injection - 100 u/ml - active: insulin lispro 100 u/ml excipient: dibasic sodium phosphate heptahydrate glycerol hydrochloric acid metacresol sodium hydroxide water for injection zinc oxide - for the treatment of patients with type 1 (iddm) and type 2 (niddm) diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.
humalog
eli lilly and company (nz) limited - insulin lispro 100 u/ml; - solution for injection - 100 u/ml - active: insulin lispro 100 u/ml excipient: dibasic sodium phosphate heptahydrate glycerol hydrochloric acid metacresol sodium hydroxide water zinc oxide - for the treatment of patients with type 1 (iddm) and type 2 (niddm) diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.
humalog mix25
eli lilly and company (nz) limited - insulin lispro 100 u/ml (3.5mg; overage 0-3%); - suspension for injection - 100 u/ml - active: insulin lispro 100 u/ml (3.5mg; overage 0-3%) excipient: dibasic sodium phosphate heptahydrate glycerol hydrochloric acid metacresol phenol protamine sulfate sodium hydroxide water for injection zinc oxide - for the treatment of patients with type 1 (iddm) and type 2 (niddm) diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.
humalog mix25 pen
eli lilly and company (nz) limited - insulin lispro 100 u/ml (3.5mg, overage 0-3%); - suspension for injection - 100 u/ml - active: insulin lispro 100 u/ml (3.5mg, overage 0-3%) excipient: dibasic sodium phosphate heptahydrate glycerol hydrochloric acid metacresol phenol protamine sulfate sodium hydroxide water for injection zinc oxide - for the treatment of patients with type 1 (iddm) and type 2 (niddm) diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.
humalog mix50
eli lilly and company (nz) limited - insulin lispro 100 u/ml (3.5mg; overage 0-3%); - suspension for injection - 100 u/ml - active: insulin lispro 100 u/ml (3.5mg; overage 0-3%) excipient: dibasic sodium phosphate heptahydrate glycerol hydrochloric acid metacresol phenol protamine sulfate sodium hydroxide water for injection zinc oxide - for the treatment of patients with type 1 (iddm) and type 2 (niddm) diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.
humalog mix50 pen
eli lilly and company (nz) limited - insulin lispro 100 u/ml (3.5mg; overage 0-3%); - suspension for injection - 100 u/ml - active: insulin lispro 100 u/ml (3.5mg; overage 0-3%) excipient: dibasic sodium phosphate heptahydrate glycerol hydrochloric acid metacresol phenol protamine sulfate sodium hydroxide water for injection zinc oxide - for the treatment of patients with type 1 (iddm) and type 2 (niddm) diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis.
lantus 100 unitsml solution for injection in a vial
sanofi-aventis singapore pte. ltd. - insulin glargine (rdna) - injection - 100 iu/ml - insulin glargine (rdna) 100 iu/ml
hypurin bovine protamine zinc 100units/ml suspension for injection 10ml vials
wockhardt uk ltd - insulin protamine zinc bovine - suspension for injection - 100unit/1ml
hypurin bovine neutral 100units/ml solution for injection 10ml vials
wockhardt uk ltd - insulin soluble bovine - solution for injection - 100unit/1ml
humalog mix25 100unitsml suspension for injection 3ml cartridges
eli lilly and company ltd - insulin lispro; insulin lispro protamine - suspension for injection - 25unit/1ml ; 75unit/1ml